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 ABSTRACT 
 The present study was investigated whether increas-
ing amounts of glucose supply have a stimulatory effect 
on the mRNA abundance and activity of key lipogenic 
enzymes in adipose tissue of midlactation dairy cows. 
Twelve Holstein-Friesian dairy cows in midlactation 
were cannulated in the jugular vein and infused with 
either a 40% glucose solution (n = 6) or saline (n = 6). 
For glucose infusion cows, the infusion dose increased by 
1.25%/d relative to the initial net energy for lactation 
(NEL) requirement until a maximum dose equating to a 
surplus of 30% NEL was reached on d 24. This maximum 
dose was maintained until d 28 and stopped thereafter 
(between d 29–32). Cows in the saline infusion group 
received an equivalent volume of 0.9% saline solution. 
Samples of subcutaneous adipose tissue were taken on d 
0, 8, 16, 24, and 32 when surplus glucose reached 0, 10, 
20, and 30% of the NEL requirement, respectively. The 
mRNA abundance of fatty acid synthase, cytoplasmic 
acetyl-coenzyme A synthetase, cytoplasmic glycerol 
3-phosphate dehydrogenase-1, and glucose 6-phosphate 
dehydrogenase showed linear treatment × dose interac-
tions with increasing mRNA abundance with increas-
ing glucose dose. The increased mRNA abundance was 
paralleled by a linear treatment × dose interaction for 
fatty acid synthase and acetyl-coenzyme A synthetase 
enzymatic activities. The mRNA abundance of ATP-
citrate lyase showed a tendency for linear treatment 
× dose interaction with increasing mRNA abundance 
with increasing glucose dose. The mRNA abundance 
of all tested enzymes, as well as the activities of fatty 
acid synthase and acetyl-coenzyme A synthetase, cor-
related with plasma glucose and serum insulin levels. In 
a multiple regression model, the predictive value of in-
sulin was dominant over that of glucose. In conclusion, 
gradual increases in glucose supply upregulate key lipo-
genic enzymes in adipose tissue of midlactating dairy 
cows with linear dose dependency. Insulin appears to be 
critically involved in this regulation. 
 Key words:   adipose tissue ,  dairy cow ,  insulin ,  lipo-
genic enzyme 
 INTRODUCTION 
 Though the liver is the key organ for lipogenesis in 
man and most mammals, adipose tissue is the predomi-
nant lipogenic site in ruminants (Ingle et al., 1973; Lali-
otis et al., 2010). A second special feature of ruminants 
is that little glucose is available for absorption under 
many dietary regimens, as most of the ingested carbo-
hydrates are fermented by microbes to short-chain FA 
(e.g., acetate, propionate, and butyrate) in the forestom-
ach (Young, 1977; Reynolds et al., 1994; Aschenbach et 
al., 2010). As a result, the lipogenic system of ruminant 
adipose tissue has adapted to use acetate rather than 
glucose as the major substrate for FA synthesis (Vernon, 
1980; Nafikov and Beitz, 2007). Nonetheless, glucose is 
required to generate the reduced NADPH needed for de 
novo FA synthesis. Glucose is also the major precursor 
for glycerol 3-phosphate used to esterify FA to triglyc-
erides (Vernon, 1980; Nafikov and Beitz, 2007). When 
glucose is supplied in excess of demand, it primarily 
increases the conversion of acetate into lipid; however, 
glucose itself can also serve as a quantitatively important 
precursor of FA synthesis in ruminant adipose tissue un-
der such circumstances (Ballard et al., 1972; Prior and 
Scott, 1980; Pearce and Piperova, 1984). 
 Many studies in nonlactating ruminants established 
that the rate of glucose incorporation into FA and activi-
ties of involved enzymes can be increased significantly 
by increasing the available glucose (Ballard et al., 1972; 
Prior and Scott, 1980). However, it is not clear whether 
these results can be extrapolated to lactating rumi-
nants, particularly dairy cows, as glucose requirements 
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and glucose distribution may grossly differ between the 
lactating and the nonlactating state (Aschenbach et 
al., 2010). Furthermore, studies designed to investigate 
the effect of surplus glucose on lipogenesis in bovine 
adipose tissue (Prior and Jacobson, 1979; Prior and 
Scott, 1980; McLeod et al., 2007) have not included 
evaluating the dose effects of surplus glucose on the 
activities and gene expression levels of adipose lipo-
genic enzymes. Therefore, the first aim of the present 
study was to investigate the dose effect of an increas-
ing intravenous glucose infusion on mRNA abundance 
and enzyme activity of the main subcutaneous adipose 
tissue (SAT) lipogenic enzymes involved in de novo 
FA synthesis in dairy cows. We considered the gene 
expressions and activities for FA synthase (FAS; EC 
2.3.1.85), an enzyme catalyzing the rate-limiting step 
in the pathway of FA synthesis de novo in bovine SAT 
(Smith and Prior, 1986), cytoplasmic acetyl-coenzyme 
A synthetase (ACS; EC 6.2.1.1) as the rate-limiting 
enzyme that controls the rate of de novo FA synthesis 
from acetate (Quraishi and Cook, 1972), and glucose 
6-phosphate dehydrogenase (G6PD; EC 1.1.1.49) as 
an enzyme involved in maintaining reduced NADPH 
supply for de novo FA synthesis. The gene expression 
of cytoplasmic glycerol 3-phosphate dehydrogenase-1 
(G3PD1; EC 1.1.1.8), an enzyme involved in glycerol 
3-phosphate synthesis from glucose being essential in 
the esterification of the FA, and of ATP-citrate lyase 
(ACLY; EC 4.1.3.8), an enzyme catalyzing the extra-
mitochondrial cleavage of citrate to oxaloacetate and 
acetyl-CoA, were also investigated. The latter enzyme 
is necessary for glucose carbon conversion into FA.
A second aim of the present study was to investigate 
whether possible changes in mRNA abundance or ac-
tivities of the above-described enzymes may be related 
to plasma glucose or insulin levels. This was especially 
important, as a previous report had questioned the 
role of insulin for lipogenesis in bovine adipose tissue 
(Smith et al., 1983).
MATERIALS AND METHODS
Animals and Experimental Design
The Regierungspräsidium Leipzig (reference 24–
9168.11, TVV 49/06) approved all experimental pro-
cedures for the study. The general experimental design 
and the production traits during the experiment have 
been described in detail in an earlier report (Al-Trad et 
al., 2009). In brief, the experiments were carried out on 
12 midlactation Holstein-Friesian cows from the dairy 
herd of the University of Leipzig. Cows had BW and 
milk yields (mean ± SEM) of 632 ± 33 kg and 25 ± 
3 kg/d, respectively, at the start of the experiment. 
Twice daily, cows were offered grass haylage (60.2% 
of total DM) and a concentrate supplement contain-
ing a commercial concentrate mix for lactating dairy 
cows (Multilac; 27.2% of total DM; Leikra GmbH, 
Leipzig, Germany) and soybean meal (12.6% of total 
DM; Al-Trad et al., 2009). The diet contained 6.72 MJ 
of NEL/kg of DM and had the following approximate 
composition (g/kg of DM); 202.1 CP, 162.5 utilizable 
protein, 33.2 ether extract, 95.4 crude ash, 231.9 ADF, 
379.0 NDF, 43.7 sugar, 112.6 starch, 22.1 K, 1.0 Na, 
7.6 Ca, 5.0 P, and 2.4 Mg. Water was available for ad 
libitum intake. Cows were milked twice daily at 0630 
and 1600 h. Cows were allocated randomly to continu-
ous intravenous glucose infusions (GI; n = 6) or saline 
infusions (SI; n = 6) over 24 h. The GI consisted of 
continuous jugular infusions of 40% glucose solution 
(40% Glukoselösung, Serumwerk Bernburg, Bernburg, 
Germany) over a period of 28 d. The infusion dose was 
calculated for each animal separately as a percentage 
of daily NEL requirements for maintenance and lacta-
tion according to NRC (2001). Net energy required for 
maintenance and lactation (MJ/d) was calculated as 
4.184 × {BW0.75 × 0.08 + milk yield (kg) × [(0.0929 
× fat %) + (0.0563 × protein %) + (0.0395 × lactose 
%)]} according to the NRC (2001). The infusion dose 
(kg of glucose/d) was calculated as designated dose 
level × NEL/(15.6 MJ/kg). The infusion dose increased 
linearly by 1.25% each day until a maximum dose of 
30% of the NEL requirement was reached at d 24. This 
maximum dose (equal to 2.65 ± 0.19 kg of glucose per 
cow per day) was maintained until d 28 (i.e., for 4 d) 
and stopped thereafter (between d 29–32). The infu-
sion protocol and the individual calculation of infusion 
volumes were identical in the SI group, except that the 
latter group received an equal volume of 0.9% SI (0.9% 
Natriumchloridlösung, Serumwerk Bernburg, Bernburg, 
Germany) as a control treatment.
Cows used in this study had daily mean plasma 
glucose and insulin concentrations that showed linear 
treatment × dose interactions between d 0 and 24 
based on increases in plasma glucose (3.78–5.49 mM; 
pooled SEM = 0.17 mM) and insulin concentrations 
(73–885 pM; pooled SEM ± 231 pM) exclusively in 
the GI group (Al-Trad et al., 2009). Over the infusion 
period, from d 0 to 24, neither daily DMI nor milk 
production were affected by the treatments; whereas, 
significant linear increases in the BW, back fat thick-
ness, and energy balance were observed in GI cows (Al-
Trad et al., 2009).
Sampling and Measurements
On d 0, 8, 16, 24, and 32, when surplus glucose 
reached 0, 10, 20, 30, and 0% of the NEL requirement, 
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SAT samples were taken alternating from the left or 
right side in the area between the tuber ischiadicum and 
tuber coxae (~3 g per biopsy) as described by Lake et 
al. (2007). Following collection, samples were washed 
immediately in ice-cold 0.9% saline solution. Sample 
aliquots for enzyme activity determinations (~1 g) were 
snap-frozen in liquid nitrogen and stored at −80°C un-
til further analysis. Samples (~300 mg) for real-time 
reverse transcription-PCR (rt-PCR) were transferred 
into tubes with 3 mL of RNAlater (Qiagen, German-
town, MD), placed in a refrigerator for 24 h, and stored 
at −20°C thereafter.
Lipogenic Enzyme Activity
Approximately 0.5 g of frozen SAT samples were 
homogenized using Ultra-Turrax T25 homogenizer 
(IKA, Staufen, Germany) in 1:10 (wt/vol) of ice-cold 
homogenization buffer (containing 30 mM of Tris-HCl, 
300 mM of sucrose, 1 mM of EDTA, and 1 mM of 
glutathione; pH 7.4). The homogenate was centrifuged 
at 40,000 × g for 45 min at 4°C and the resulting su-
pernatant was used to determine FAS, G6PD, and ACS 
activities.
The enzyme activities of FAS and ACS were deter-
mined using modifications of the previously described 
radiochemical assays of Lu and Archer (2007) and Lu-
ong et al. (2000), respectively. The FAS assays were 
conducted in a final volume of 0.2 mL at 39°C for 30 
min, in the presence of 100 mM of potassium phosphate 
(pH 6.8), 0.5 mM of NADPH, 1 mM of dithiothreitol, 
0.05 mM of acetyl-CoA, 0.05 mM of malonyl-CoA, and 
555 Bq of [14C]malonyl-CoA. Reactions were terminated 
by the addition of 1 mL of ice-cold 1 N HCl/methanol 
(6:4, vol/vol) and the FA were extracted with 1 mL 
of petroleum ether. Following centrifugation at 5,000 
× g for 5 min at room temperature, the incorporation 
of radioactivity into the FA was assessed in the up-
per phase by a liquid scintillation counter (Tri-Carb 
2100TR, Perkin Elmer, Waltham, MA). Results were 
corrected for blanks where NADPH was omitted from 
the reaction mixture.
Each reaction mixture for ACS assays contained the 
following components in a final volume of 0.25 mL: 60 
mM of potassium phosphate (pH 7.5), 3 mM of ATP, 
0.1 mM of CoA, 4 mM of MgCl2, 1 mM of Dithiothrei-
tol, 0.24 mM of sodium acetate, and 555 Bq of sodium 
[14C]acetate. Reactions were incubated at 39°C for 30 
min, after which the reaction was stopped by adding 
100 μL of ice-cold 20% (wt/vol) trichloroacetic acid. 
Thereafter, a 20-μL aliquot of the reaction mixture was 
spotted onto Whatman qualitative filter papers (What-
man International Ltd., Maidstone, UK), washed 2 
times with 7:1 ether-formic acid, and air-dried. The 
amount of [14C]acetyl-CoA formed was determined by 
counting the washed papers in a scintillation counter 
(Tri-Carb 2100TR). Blank readings were generated by 
omitting CoA from the reaction mixture.
Glucose 6-phosphate dehydrogenase catalytic activity 
was assayed photometrically (U-2000 UV/Vis Spectro-
photometer, Hitachi High Technologies America Inc., 
Pleasanton, CA) at 39°C by measuring the NADP+ to 
NADPH ratio during catalytic conversion of glucose 
6-phosphate to 6-phosphogluconolactone at 340 nm 
(Chilliard et al., 1991).
RNA Isolation and Quantitative rt-PCR Analysis
An automated RNA purification protocol from SAT 
stored in RNAlater was carried out on the QIAcube 
instrument (Qiagen, Hilden, Germany) using the 
RNeasy Lipid Tissue Mini Kit (Qiagen) according to 
the manufacturer’s instructions. The quality of RNA 
was assessed using the Agilent 2100 Bioanalyzer (Agi-
lent Technologies GmbH, Vienna, Austria). Samples 
had an average RNA integrity value of 6.9. Total RNA 
(100 ng) was reverse transcribed using random prim-
ers in a 20-μL reaction of the High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, Foster 
City, CA) according to the manufacturer’s instructions. 
Reverse transcription reactions were carried out on a 
StepOnePlus (Agilent Technologies GmbH) at 25°C for 
10 min followed by 37°C for 120 min and 85°C for 5 min. 
The resulting first-strand cDNA was stored at −80°C 
until use for rt-PCR. Beta-2 microglobulin (B2M) was 
used as nonregulated reference gene.
Polymerase chain reaction primers and dual-labeled 
fluorescent probes (Table 1) were designed using the 
web-based real-time PCR primer design software pro-
vided by Genscript Inc. (Piscataway, NJ; http://www.
genscript.com) and synthesized by MWG Biotech AG 
(Ebersberg, Germany). For each sample, the target 
gene and the control gene were run under duplex reac-
tion conditions in duplicate using Rotor-Gene Multi-
plex PCR Kit (Qiagen) on a Rotor-Gene 6000 (Qiagen) 
with 72 tubes per rotor. The following reagents were 
used for amplification in 10 μL of final volume: 1 μL 
of sample cDNA, 5 μL of Rotor-Gene Multiplex PCR 
Master Mix (Qiagen), 500 nmol of each primer, and 
200 nmol of each probe for the genes of interests and 
B2M. Amplification conditions for quantification were 
95°C for 5 min and 40 cycles of 95°C for 20 s and 60°C 
for 20 s. After the amplification efficiency of each tar-
get and reference gene was validated, the relative gene 
expression levels were determined by the 2−ΔΔCTmethod 
as described previously (Livak and Schmittgen, 2001). 
Gene expression was expressed as the normalized ratio 
of gene expression relative to B2M mRNA. A pooled 
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sample from d 0, containing equal volumes from 1 ani-
mal of the SI and 1 animal of the GI group, was used 
as an interplate calibrator.
Calculations and Statistical Analysis
Statistical analyses of data were performed using the 
PROC MIXED procedure of SAS (SAS, 2002) account-
ing for repeated measures. The model for analyses of 
treatment and dose effects during increasing glucose 
infusions (d 0–24) included the fixed effects of treat-
ment (GI vs. SI), dose (representing dose levels of 0, 10, 
20, and 30% NEL requirement), and their interaction. 
The NEL calculated before the start of the experiment 
was used as a covariate. In addition, because cows were 
gradually exposed to increasing dose levels, dose was 
included in the model as a repeated measure. The co-
variate error structure that yielded the lowest Akaike’s 
and Bayesian information criterion values for each de-
pendent variable was used. When significant treatment 
× day interactions were detected, means were separated 
using a Bonferroni mean separation test. To determine 
the effect of infusate dose over time, the linear and qua-
dratic effects of dose and their interaction with treat-
ment were tested. The model included the fixed effect 
of treatment (GI vs. SI) and the NEL calculated before 
the start of the experiment was used as a covariate. For 
this analysis, dose was considered to be a continuous 
variable. Comparisons of postinfusion samples (d 32) 
to preinfusion samples (d 0) were performed using a 
Student’s paired t-test.
Linear and multiple linear correlation coefficients, as 
well as the linear regression parameters (intercept and 
slope), their error terms (SE), and the predictive value 
of multiple regression variables, were estimated using 
the software Sigma Plot 11 (Systat Software GmbH, 
Erkrath, Germany). Only values determined during the 
infusion period (d 0–24; 4 values per cow) were used 
for the correlation and regression analyses of plasma 
glucose and serum insulin concentrations with each 
other and with the mRNA abundance and activity of 
lipogenic enzymes. Plasma glucose and serum insulin 
concentrations were derived from Al-Trad et al. (2009; 
see also footnote 1 to Table 3). Differences were consid-
ered significant when P < 0.05. Trends are discussed 
when P < 0.10.
RESULTS
Lipogenic enzyme activities and relative mRNA 
abundances are listed in Table 2. The relative mRNA 
abundance of FAS showed a treatment effect (P < 0.05), 
linear dose effect (P < 0.05), and linear treatment × 
dose interaction (P < 0.01) based on an increase in 
FAS mRNA abundance in the GI group with increasing 
glucose dose but no change over time for the SI treat-
ment. The increased abundance of FAS mRNA in the 
GI group corresponded with an increase in FAS activity 
(linear treatment × dose interaction; P < 0.01). The 
relative mRNA abundance of the cytoplasmic ACS also 
showed a linear dose effect (P < 0.05) with a linear 
treatment × dose interaction (P < 0.05), which cor-





range Primer and probe sequence2
B2M BC118352.1 102–123 Forward: 5c-AGCGTCCTCCAAAGATTCAAGT-3c
137–168 Probe: 5c-FAM-CACCAGAAGATGGAAAGCCAAATTACCTGAA-BHQ1–3c
169–192 Reverse: 5c-GGATGGAACCCATACACATAGCA-3c
FAS AY343889.1 741–760 Forward: 5c-ATCAGGGAATGGCTACTGCC-3c
787–811 Probe: 5c-CY5-CTGACCAAGAAGTCCCTGGCCCGAC-BHQ2–3c
815–834 Reverse: 5c-GTTGAGGATGGTGGCGTACA-3c
ACS BC134532.1 530–548 Forward: 5c-GACCGAGTGGCCATCTACA-3c
551–573 Probe: 5c-HEX-CCCATGATCCCGGAGCTCGTGGT-BHQ1–3c
604–625 Reverse: 5c-CGCAAACACAATGGAGTGCAGA-3c
G3PD1 BC105513.1 442–462 Forward: 5c-CAACGAGGTGGCTGATGAGAA-3c
474–503 Probe: 5c-ROX-CAACCATTGGTAGCAAGAACCAGGCTCATG-BHQ2–3c
533–552 Reverse: 5c-ACCGTGATGCGGAAATTGGG-3c
G6PD AY862878.1 121–141 Forward: 5c-GAGCCCTTCTTCAAAGCTACC-3c
178–200 Probe: 5c-ROX-CGCAACTCCTACGTGGCCGGCCA-BHQ2–3c
204–223 Reverse: 5c-TGTAGGAGGCAGTGTCATCG-3c
ACLY BC108138.1 1,061–1,080 Forward: 5c-CCAGATGGCAAGATCCTCAT-3c
1,081–1,103 Probe: 5c-ROX-CATCGGAGGCAGCATCGCAAACT-BHQ1–3c
1,173–1,192 Reverse: 5c-AAAGATCGTGACCTCGTGCT-3c
1B2M = β2 microglobulin; FAS = FA synthase; ACS = cytoplasmic acetyl CoA synthetase; G3PD1 = cytoplasmic glycerol 3-phosphate dehy-
drogenase 1; G6PD = glucose 6-phosphate dehydrogenase; ACLY = ATP-citrate lyase.
2FAM = 6-carboxyfluorescein; TAMRA = 6-carboxytetramethylrhodamine; JOE = 2,7-dimethoxy-4,5-dichloro-6-carboxyfluorescein; ROX = 
6-carboxy-X-rhodamine; BHQ = blackhole quencher.
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responded to linear and quadratic treatment × dose 
interactions (P < 0.05) for ACS activity. Interactions 
resulted from a dose-dependent, selective increase in 
mRNA abundance of ACS that was paralleled by a nu-
merical increase in ACS activity in the GI group only.
Cytoplasmic G3PD1 mRNA abundance was greater 
for GI than SI (treatment effect; P < 0.05) with a linear 
treatment × dose interaction (P < 0.05). The inter-
action was based on a numerical increase in G3PD1 
mRNA abundance in the GI group with increasing 
glucose dose; whereas G3PD1 mRNA abundance of the 
SI group showed a numerical decrease over time.
Treatment affected G6PD mRNA abundance (P < 
0.05), with a linear dose effect (P < 0.05) and linear 
treatment × dose interaction (P < 0.01). The latter was, 
again, based on increases in G6PD mRNA abundance 
in the GI but not the SI group. However, the activity 
of G6PD was not affected by treatment, dose, or their 
interactions. The mRNA abundance of ACLY showed 
tendencies for a treatment effect, linear and quadratic 
dose effects, and linear and quadratic treatment × dose 
interactions (P < 0.10); this was based on a ~20-fold 
numerical increase in ACLY mRNA abundance in the 
GI group at the highest infused glucose dose compared 
with a numerical decrease in the SI group.
Except for G3PD1, abundances of mRNA were 
higher (FAS, G6PD, ACLY; all P < 0.05) or tended 
to be higher (ACS; P = 0.087) on d 32 compared with 
preinfusion values (d 0) in the GI group only (Table 2). 
For FAS and ACS, this tended to coincide (P = 0.058) 
or coincided (P < 0.01) with increased activity in the 
GI group 4 d after the end of infusion (d 32) compared 
with preinfusion values (d 0).
To elucidate whether the observed changes in mRNA 
abundance and activities might be related to the avail-
ability of glucose or insulin in the blood, simple linear 
correlation and regression analyses were performed. 
Serum insulin concentration was positively correlated 
with the mRNA abundances of all tested enzymes, as 
well as with the activities of FAS and ACS (P < 0.01; 
Table 3). The R2-value for these correlations varied 
between 0.20 and 0.42. Only G6PD activity was not 
correlated to serum insulin, having a slope not different 
from zero. With the exception of ACLY, all regressions 
had an intercept that was (P < 0.05) or tended (ACS 
mRNA only; P = 0.052; Table 3) to be different from 
zero.
Serum insulin concentration itself was related to 
plasma glucose concentration (R2 = 0.58; P < 0.001; 
Table 3). The respective regression had a significant 
but negative intercept (P < 0.001; Table 3). Negative 
intercepts were also observed for regression between 
plasma glucose concentration and the mRNA abun-
dance of FAS, ACS, G6PD, and ACLY (P < 0.05) 
and, as a trend, for FAS activity (P = 0.055; Table 3). 
Furthermore, all measured mRNA abundances, as well 
as FAS and ACS activities, correlated with plasma glu-
cose concentrations (P < 0.01), albeit their correlation 
coefficients were in all instances numerically smaller 
than those calculated for the relationships with insulin 
(Table 3).
Multiple linear regression analysis with the combined 
parameters plasma glucose and serum insulin also re-
vealed correlations for all mRNA abundances tested, as 
well as for FAS and ACS activities (P < 0.005; Table 
3). The serum concentration of insulin was suitable to 
predict the mRNA abundances of ACS, G6PD1 and 
ACLY (P < 0.05), and tended to be suitable to predict 
the mRNA abundance of FAS (P = 0.055), as well as 
the activities of FAS (P = 0.053) and ACS (P = 0.087). 
By contrast, plasma glucose concentration was not pre-
dictive for any of the measured mRNA abundances or 
enzyme activities in this combined regression approach 
(Table 3). None of the regressions had an intercept dif-
ferent from zero.
DISCUSSION
Consistent with the nutritional strategy, ruminant 
adipose tissue uses acetate originating from ruminal 
fermentation rather than glucose as the major sub-
strate for lipid synthesis (Vernon, 1980; Nafikov and 
Beitz, 2007). The minor role of glucose as a precursor 
for lipogenesis in ruminant adipose tissue is reflected 
by a low activity of enzymes of the citrate-cleavage 
pathway (e.g., ACLY) that are involved in the conver-
sion of glucose to acetyl-CoA (Bauman, 1976; Laliotis 
et al., 2010). Nonetheless, glucose incorporation into 
FA can be enhanced substantially by postruminal or 
intravenous glucose infusions (Bauman, 1976). In a 
previous study, we had observed marked increases in 
back fat thickness and BW during increasing intrave-
nous glucose infusion (Al-Trad et al., 2009). As milk 
performance was completely unaffected by surplus 
glucose supply, we concluded that midlactation dairy 
cows on an energy-balanced diet directed any surplus of 
glucose predominantly to body fat reserves and not to 
increased lactation performance (Al-Trad et al., 2009). 
Total lipid content of the liver was also not affected 
(Al-Trad et al., 2010a), which supports the hypothesis 
that adipose tissue is the key player in lipogenesis dur-
ing excessive glucose infusions. However, it remained 
unknown whether increased lipogenesis was simply the 
result of increased substrate availability or whether the 
enzymatic capacity of the lipogenic pathway increased 
in parallel. Therefore, the present study was specifically 
designed to evaluate the effects of increasing glucose 
supply on key lipogenic enzymes in the adipose tissue 
4304 CARRA ET AL.
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of midlactating dairy cows. The intention was to ex-
plore the whole range of nutritionally relevant surplus 
glucose (Al-Trad et al., 2010b). The infusion protocol 
was specifically designed to not interfere with daily feed 
intake. Thus, the samples obtained and used for the 
present study were from animals consuming constant 
ad libitum levels of feed on which a defined dose of 
glucose was added as surplus energy (Al-Trad et al., 
2009). Activities of FAS, ACS, and G6PD were mea-
sured in the current study simultaneously with their 
mRNA abundance in response to gradual shifts from 
a slightly negative energy balance at the beginning of 
the experiment into a strong positive energy balance 
when infusing glucose at 30% NEL requirement at d 24 
(Al-Trad et al., 2009).
Fatty acid synthase is a key enzyme in the lipogenic 
pathway that catalyzes the terminal, rate-limiting steps 
involved in the de novo synthesis of FA (Laliotis et al., 
2010). Fatty acid synthase represents a complex and 
multifunctional protein containing all the catalytic com-
ponents that are required for a series of 37 sequential 
reactions, leading to the formation (in the presence of 
NADPH) of palmitic acid (Aguilar and Diegode, 2006). 
In all species, this enzyme is highly regulated by nutri-
ents and hormones, including a prominent regulation 
by insulin via different transcription-enhancing effects 
(Kersten, 2001; Griffin and Sul, 2004). In sheep, starva-
tion causes a decrease in the activity of FAS, whereas 
refeeding restores it (Ingle et al., 1973). When reaching 
the highest levels of surplus glucose supply (equating to 
30% NEL requirement) in the present study, the mRNA 
abundance and activity of the FAS enzyme increased to 
about 10 times the level of saline-infused control cows, 
indicating that de novo FA synthesis was enhanced in 
the GI group. The increase in FAS enzyme activity is 
consistent with previous results from Prior and Scott 
(1980), who observed a doubling of FAS activity after 
intravenously infusing 500 g/d of glucose into steers 
weighing 360 kg. The current study additionally pro-
vides evidence that the upregulation of FAS enzyme is 
triggered, at least to a significant part, by an increase 
of FAS gene transcription.
Acetate is the predominant VFA produced in the ru-
men by microbial fermentation (Aluwong et al., 2010; 
Aschenbach et al., 2011). Acetate enters the common 
lipogenic pathway after initial activation by ACS in the 
presence of CoA to acetyl-CoA, an initial substrate for 
lipogenesis (Knowles et al., 1974). Accordingly, ACS has 
been identified as a main rate-limiting enzyme involved 
in acetate utilization by ruminant tissues (Quraishi 
and Cook, 1972). Previous studies have revealed that 
carbohydrate feeding or infusion of glucose significantly 
increased the in vitro rate of acetate incorporation into 
FA in ovine (Ballard et al., 1972) and bovine adipose 
tissue (Prior and Scott, 1980). In the present study, 
a 5-times higher ACS activity for GI versus SI cows 
during the high rate (30% NEL) of glucose infusion was 
paralleled by an almost 10-times greater ACS mRNA 
abundance, suggesting partial regulation of ACS ac-
tivity by gene transcription. Similarly to FAS, tran-
scriptional regulation of ACS has also been ascribed to 
insulin, primarily, via an activation of the peroxisome 
proliferator-activated receptor γ downstream the insu-
lin signaling cascade (Kersten, 2001).
Transcriptional regulation by insulin is also promi-
nent for ACLY. Injections of insulin into diabetic rats 
immediately increase hepatic ACLY mRNA and also, 
with a delay of 24 h, its enzyme activity (Fukuda et al., 
1992). As such, transcriptional upregulation of ACLY 
activity, presumably by insulin, can be extrapolated for 
SAT of dairy cows when combining our ACLY mRNA 
data with the upregulation of ACLY activity observed 
after glucose infusion (Prior and Scott, 1980) or high-
energy feeding of steers (Schoonmaker et al. 2004). 
Nevertheless, the study by Prior and Scott (1980) also 
showed that acetate remains the most important sub-
strate for lipogenesis after intravenous glucose infusions 
despite an upregulation of ACLY, which is the key 
enzyme for glucose carbon integration into FA.
The de novo synthesis of FA in adipose tissue re-
quires a substantial amount of reducing equivalents in 
the form of NADPH for the reduction of acetyl-CoA 
to FA (Laliotis et al., 2010). In ruminants, around 50 
to 80% of the NADPH necessary to support FA syn-
thesis is produced by glucose oxidation via the pentose 
phosphate pathway (Nafikov and Beitz, 2007). Glucose 
6-phosphate dehydrogenase has been identified as the 
main rate-limiting enzyme involved in this process 
(Laliotis et al., 2010). Accordingly, an increase of G6PD 
transcription with an increasing glucose dose may seem 
an appropriate measure to increase NADPH avail-
ability for lipogenesis during surplus glucose supply. 
An increase in G6PD mRNA abundance was, indeed, 
observed in the GI cows of the present study, which can 
most likely be ascribed to the well-established regula-
tion of G6PD transcription by insulin (Wagle et al., 
1998). However, increased G6PD mRNA transcription 
did not lead to higher enzyme activity, implicating 
that upregulation of the G6PD enzyme activity was 
prevented at posttranscriptional levels. This unex-
pected finding reflects the complex posttranscriptional 
regulation of G6PD enzyme activity (Stanton, 2012), 
and may well accommodate the metabolic needs when 
acknowledging (1) that huge increases in glucose sup-
ply will increase NADPH generation by G6PD despite 
constant G6PD enzyme activity and (2) that cattle 
adipose tissue alternatively enforces minor pathways 
of NADPH generation (NADP-malate dehydrogenase, 
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NADP-isocitrate dehydrogenase) in times of increased 
glucose supply (Prior and Scott, 1980).
The formation of triglycerides from FA (i.e., adipo-
genesis) requires glycerol. The final steps of glycerol 
synthesis in adipocytes are controlled by G3PD, which, 
in turn, may also be transcriptionally upregulated by 
insulin upon glucose excess (Bhandari et al., 1991). The 
upregulation of the cytosolic G3PD-1 isoform observed 
in GI cows of the present study is, therefore, reflective 
of the increased demand for glycerol during lipogenesis 
in glucose-infused cows.
As elaborated above, all enzymes investigated in the 
present study are known to be transcriptionally regu-
lated by insulin, and many downstream transcription 
factors and transcription events have been identified in 
rodent and cell culture models (Kersten, 2001; Griffin 
and Sul, 2004). By contrast, the relevance of insulin 
for the regulation of lipogenic enzymes in the bovine 
has been questioned 30 yr ago (Smith et al., 1983). 
Therefore, it was a second aim of the present study 
to investigate whether the studied enzymes are under 
the control of insulin in dairy cows. Highly significant 
correlations between serum insulin concentrations and 
mRNA abundances strongly support the conclusion 
that all of the investigated enzymes are transcription-
ally regulated by insulin in the dairy cow, too. The R2-
values for the correlations varied between 0.20 and 0.42, 
indicating that 20 to 42% of the variation in enzyme 
mRNA abundances was explainable by variation in se-
rum insulin levels. For FAS, ACS, G3PD1, and G6PD, 
the regression lines had intercepts different from zero 
(i.e., a significant part of mRNA abundance was not 
related to insulin). Those intercepts were rather close 
to the baseline mRNA expression levels in noninfused 
cows, indicating that insulin regulation of these genes 
becomes especially relevant at elevated serum insulin 
concentrations. The latter may explain why it was dif-
ficult to delineate a regulatory function of insulin on 
lipogenic enzyme expression in a previous study (Smith 
et al., 1983). For ACLY, however, the regression did not 
possess a significant intercept, indicating that insulin 
is most likely an essential factor to initiate any level of 
transcription.
At variance to the just proposed role of insulin, the 
earlier study by Smith et al. (1983) came to the con-
clusion that glucose infusion per se, but not increased 
insulin availability, is responsible for an increase in 
lipogenic enzyme activity in bovine adipose tissue. 
Similarly, Kreipe et al. (2011) showed that a decrease 
of plasma glucose concentration by a hyperinsulinemic 
hypoglycemic clamp in dairy cows induces a decrease 
in hepatic FAS mRNA abundance despite the concur-
rently increased plasma insulin concentrations. This 
may be explained from studies in rodents and cell cul-
tures that point to an essential role of costimulation of 
insulin pathways by glucose to induce the transcription 
of lipogenic enzymes. Costimulation by glucose possi-
bly converges at the sterol regulatory element-binding 
protein (SREBP)-1c transcription factor (Foretz et al., 
1999), which plays a pivotal role for insulin-mediated 
stimulation of FAS and other lipogenic enzymes (Grif-
fin and Sul, 2004). In the present study, significant cor-
relations were indeed observed between plasma glucose 
concentration and the mRNA abundance of all tested 
enzymes, as well as the activities of FAS and ACS. 
However, all simple regressions between plasma glucose 
concentrations and the significantly correlated mRNA 
abundances or enzyme activities possessed rather 
unusual negative intercepts. The latter can be most 
logically explained when commonly attributing them to 
the negative intercept of the regression between plasma 
glucose and serum insulin concentrations, thereby, in-
terpreting glucose correlations as cocorrelations rather 
than causative correlations. This suspicion was further 
corroborated when fitting multiple linear regressions. In 
multiple linear regressions, the serum values of insulin 
were always better (and mostly significantly) predic-
tive for the level of transcription of lipogenic enzymes 
as opposed to plasma glucose concentration. Though 
we fully acknowledge that glucose may be required to 
elicit increased transcription of lipogenic enzymes, the 
quantitative level of their mRNA abundance appears to 
be better related to the concentration of serum insulin 
when glucose is not limiting.
CONCLUSIONS
In conclusion, dairy cows preserved the ability to 
deposit any level of excess energy efficiently in adipose 
tissue. This was specifically verified for energy from 
glucose, which is usually considered a precious and 
limited energy source for dairy cows that rely on gluco-
neogenesis for glucose homeostasis. Because of the high 
metabolic priority for glucose production and conserva-
tion, it appeared a challenging question at which dose 
the metabolic switch turns adipose tissue into a main 
glucose metabolizing tissue. In our study, this switch 
operates in linear dose dependence on glucose oversup-
ply, meaning that already moderate doses of glucose 
initiate a preferential deposition of the excess energy 
into fat. On the molecular level, this is based on linear 
increases in the transcription of genes involved in lipo-
genesis and adipogenesis, which are best predictable 
from the increases in serum insulin concentrations. For 
FAS and ACS, linearly increased gene transcription is 
followed by linearly increased enzyme activity. How-
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ever, an increase in enzyme activity was not observed 
for G6PD despite increased mRNA abundance, which 
may point to an increasing importance of alternative 
pathways of NADPH generation under such conditions.
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